GTX-104 is a clinical stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aSAH patients to address significant unmet medical needs. The unique ...
The number of food safety alerts and fraud investigations exchanged between European member states went up in 2023. The European Commission, which manages ...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...
Hosted on MSN7mon
How savvy snowbirds can find quality healthcare in the SouthAndrea Wickstrom, BSN, PHN, RN, has been a nurse for 25 years. Most of her experience is in cardiology at the bedside, stress testing, and with cardiac medical devices. Health literacy is also a ...
In a bid to transform Katherine's approach to justice by focusing on community-led solutions to build a safer and more ...
The Boar’s Head deli meat plant in Jarratt, Virginia, was shut down indefinitely after being linked to a deadly listeria ...
Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate ...
GTX-104 is a clinical stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aSAH patients to address significant unmet medical needs. The unique ...
GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side ...
Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback